HomeInsights52 Week Low Stocks

Astrazeneca Pharma India Ltd 52 Week Low

Astrazeneca Pharma India Ltd 52 Week Low

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

0.3 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

YEARLOW

₹ 4050.15

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week Low of Astrazeneca Pharma India Ltd is ₹ 4050 as of 26 Dec 24 .

Company Fundamentals for Astrazeneca Pharma India Ltd

No data available

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20246378.7
24 Dec 20246425.7
23 Dec 20246469.5
20 Dec 20246496.85
19 Dec 20246505.85
18 Dec 20246480.7
17 Dec 20246532.25
16 Dec 20246607.75
13 Dec 20246603.6
12 Dec 20246636

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Astrazeneca Pharma India Ltd News Hub

News

AstraZeneca gets CDSCO nod to import cancer drug, Lynparza

This approval establishes the use of Olaparib in combination with Durvalumab as a maintena...

Read more

26 Nov 2024 14:49

News

AstraZeneca Pharma gains on plan to launch COPD drug

Earlier, on 2 December 2023, the pharma company intimated about the receipt of import and ...

Read more

19 Nov 2024 12:11

News

AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr

Revenue from operations jumped 31.16% year on year (YoY) to Rs 408 crore in the quarter en...

Read more

14 Nov 2024 12:34

News

Astrazeneca Pharma India to announce Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

25 Oct 2024 16:11

News

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...

Read more

24 Sep 2024 08:54

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and Nation...

Read more

24 Sep 2024 12:00

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Astrazeneca Pharma India Ltd

Why is it important to track the 52-week low of Astrazeneca Pharma India Ltd stocks?

Investors should monitor the 52-week low of Astrazeneca Pharma India Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Astrazeneca Pharma India Ltd stocks hitting a 52-week low?

Factors leading to Astrazeneca Pharma India Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Astrazeneca Pharma India Ltd stocks when they hit a 52-week low?

Buying Astrazeneca Pharma India Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Astrazeneca Pharma India Ltd stocks?

Investors should monitor the 52-week low of Astrazeneca Pharma India Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Astrazeneca Pharma India Ltd stock at their 52-week low?

An investor can analyze the reasons for the Astrazeneca Pharma India Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Astrazeneca Pharma India Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Astrazeneca Pharma India Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Astrazeneca Pharma India Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions